Qiagen agreed to EUR 46.50 offer for Qiagen stock

Published on 10/27/2026 at 11:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 sales reached USD 548 million on October 21, 2026. Qiagen stock costs EUR 45.14 on October 27, 2026 versus EUR 45.10 at Xetra.

Takeover and results timeline

EQT offered EUR 46.50 per Qiagen share on October 21, 2026.
Third-quarter sales reached USD 548 million and adjusted earnings per share reached USD 0.65.
Qiagen stock trades at EUR 45.14 at 11:07 a.m. CEST at Lang & Schwarz on October 27, 2026, 0.09 percent above the Xetra close of October 26, 2026.
Full third-quarter results are scheduled for November 4, 2026.

Qiagen, NL0015002SN0, Illustration mit AI erstellt.

Qiagen (ISIN NL0015002SN0) entered into a takeover agreement with EQT on October 21, 2026, offering EUR 46.50 per share, while preliminary third-quarter sales reached USD 548 million and adjusted diluted earnings per share came to USD 0.65, as Financial Times reported on October 21, 2026. The offer puts deal completion, rather than a fresh operating forecast, at the center of the investment case.

Offer terms set the reference point

The all-cash proposal values each share at EUR 46.50. Qiagen had suspended its full-year 2026 outlook while the transaction remains pending, a decision disclosed in the company release dated October 21, 2026, and linked through Qiagen. That suspension limits the usefulness of standalone full-year estimates until the proposed transaction advances.

What does the latest quarter show?

The preliminary figures point to continued operating activity before the proposed ownership change. Sales of USD 548 million in the third quarter of 2026 exceeded the USD 535.04 million reported for the second quarter of 2026, an increase of USD 12.96 million, while adjusted diluted earnings per share rose from USD 0.62 to USD 0.65, according to MarketBeat. The comparison is positive, but the suspended outlook means the transaction remains the stronger near-term valuation anchor.

Three dates frame the story

On July 8, 2026, Qiagen traded at a Xetra close of EUR 33.15 before takeover interest became public. On October 21, 2026, the company disclosed the EUR 46.50 cash offer and preliminary third-quarter sales of USD 548 million. On October 27, 2026, the Lang & Schwarz quote stood at EUR 45.14, leaving the price EUR 1.36 below the proposed consideration.

Dates investors can track

Qiagen plans to publish full third-quarter 2026 results on November 4, 2026, at approximately 22:05 Frankfurt time, according to the company release. The transaction is also subject to shareholder, regulatory and other closing conditions described in the October 21 announcement.

Stock stays near the offer value

The stock was trading at EUR 45.14 at Lang & Schwarz on October 27, 2026 at 11:07 a.m. CEST, up EUR 0.04, or 0.09 percent, versus the Xetra close of October 26, 2026 at EUR 45.10. The quote sits EUR 1.36 below the proposed cash consideration. The further course of trading is shown by the continuously updated real-time quote of Qiagen stock.